BAY85-8102 F-18
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY85-8102 F-18, covering 2013-07-31 to 2013-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers [Phase 1]